11 results match your criteria: "University at Buffalo - State University of New York (SUNY)[Affiliation]"
Ophthalmol Glaucoma
October 2024
Department of Ophthalmology and Ira G. Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/State University of New York (SUNY), Buffalo, New York.
Case Rep Ophthalmol Med
May 2024
Department of Ophthalmology, Ross Eye Institute, University at Buffalo/State University of New York (SUNY), 1176 Main St., Buffalo, NY 14209, USA.
. We describe a patient with normal tension glaucoma (NTG) of several years whose management was complicated by the presence of a giant internal carotid-ophthalmic artery aneurysm. .
View Article and Find Full Text PDFCommun Biol
January 2024
Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation; Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, CA, USA.
We conducted a genome-wide association study (GWAS) in a multiethnic cohort of 920 at-risk infants for retinopathy of prematurity (ROP), a major cause of childhood blindness, identifying 1 locus at genome-wide significance level (p < 5×10) and 9 with significance of p < 5×10 for ROP ≥ stage 3. The most significant locus, rs2058019, reached genome-wide significance within the full multiethnic cohort (p = 4.96×10); Hispanic and European Ancestry infants driving the association.
View Article and Find Full Text PDFOphthalmol Glaucoma
May 2024
Department of Ophthalmology and Ira G. Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/State University of New York (SUNY), Buffalo, New York. Electronic address:
Purpose: To investigate associations between pigmentation of the trabecular meshwork (PTM) and other preoperative eye characteristics and outcomes of minimally invasive glaucoma surgery combined with phacoemulsification (Phaco/MIGS).
Design: Retrospective interventional case series.
Participants: Academic glaucoma clinic patients with symptomatic cataract and glaucoma treated with combined Phaco/MIGS.
Int Ophthalmol
May 2021
Department of Ophthalmology and Ira G. Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/State University of New York (SUNY), 1176 Main Street, Buffalo, NY, 14209, USA.
Purpose: To determine whether Tonopen intraocular pressure (IOP) measurements by Ophthalmic technicians are interchangeable with Goldmann applanation tonometry (GAT) by a specialist in our glaucoma clinic.
Methods: Ophthalmic technician Tonopen and glaucoma specialist GAT IOP measurements were performed on both undilated eyes of 300 consecutive patients during the same visit to our glaucoma clinic.
Results: Among all 600 eyes of 300 patients (age 65.
Precis: Combining Trabectome or iStent with phacoemulsification equally reduces intraocular pressure (IOP) and IOP-lowering medication burden during a 24-month follow-up, with a possible advantage to the Trabectome in the early postoperative period.
Purpose: Intrasubject same-surgeon comparison between phacoemulsification combined with Trabectome (Phaco/Trabectome) versus one first-generation iStent (Phaco/iStent).
Settings: Private glaucoma and cataract practice.
Appl Ergon
January 2020
University at Buffalo - State University of New York (SUNY), 12 Capen Hall, Buffalo, NY, 14260, USA.
'Safety-II' is a new approach to safety, which emphasizes learning proactively about how safety and efficacy are achieved in everyday frontline work. Previous research developed a new lesson-sharing tool designed based on the Safety-II approach: Resilience Engineering Tool to Improve Patient Safety (RETIPS). The tool comprises questions designed to elicit narratives of adaptations that have contributed to effectiveness in care delivery.
View Article and Find Full Text PDFJAMA Netw Open
August 2019
Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Importance: Surgery followed by adjuvant chemotherapy or chemoradiation is widely used to treat resectable pancreatic cancer. Although studies suggest initiation of adjuvant therapy within 12 weeks of surgery, there is no clear time interval associated with better survival.
Objective: To evaluate the ideal timing of adjuvant therapy for patients with stage I to II resected pancreatic cancer.
Int Ophthalmol
March 2019
Department of Ophthalmology and Ira G. Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/State University of New York (SUNY), 1176 Main Street, Buffalo, NY, 14209, USA.
Purpose: To review the clinical course and outcomes of 3 phakic, ischemic, and inflamed eyes in which we performed urgent tube shunt implantation through the ciliary sulcus without lensectomy.
Methods: This is a retrospective interventional case series. Three eyes of 3 diabetic patients with uncontrolled severe neovascular glaucoma, shallow anterior chambers with closed angles and poor view to the posterior segment, where concomitant lensectomy was not recommended due to uncontrolled uveitis and ischemia, underwent tube shunt implantation through the ciliary sulcus.
Exp Eye Res
August 2017
Department of Ophthalmology, University at Buffalo-State University of New York (SUNY), Buffalo, NY, USA; SUNY Eye Institute, Buffalo, NY, USA; Department of Biochemistry and Neuroscience Program, University at Buffalo- State University of New York (SUNY), Buffalo, NY, USA; Research Service, VA Western New York Healthcare System, Buffalo, NY, USA. Electronic address:
A duplex fluorescence assay to assess the viability of cells cultured in multi-well plates is described, which can be carried out in the original culture plate using a plate reader, without exchanges of culture or assay medium, or transfer of cells or cell supernatant. The method uses freshly prepared reagents and does not rely on a proprietary, commercially supplied kit. Following experimental treatment, calcein acetoxymethyl ester (CaAM) is added to each well of cultured cells; after 30 min, the fluorescence intensity (emission λ ∼ 530 nm) is measured.
View Article and Find Full Text PDFSAGE Open Med Case Rep
August 2016
Temple University, Philadelphia, PA, USA.
Objective: We presented a rare case of recurrent hepatocellular carcinoma after liver transplant manifested as an isolated mediastinal mass.
Methods: A 62-year-old man was referred for evaluation of atypical chest pain and abnormal finding of a computed tomography of the chest. He had history of chronic hepatitis C liver cirrhosis and hepatocellular carcinoma underwent orthotopic liver transplant as a curative treatment three years earlier.